Quantum Computing market Trends, Analysis by 2035

As per Roots Analysis, in order to overcome various challenges related to drug discovery, such as preclinical failure rates, increased time period and heavy capital investments, several pharmaceutical players are currently exploring the potential of quantum computing in drug discovery processes. 

The use of quantum computing in drug discovery is likely to improve the overall R&D productivity by providing better clinical outcomes with accurate predictions of a drug molecule’s properties. Overall, this domain is anticipated to gain significant traction, in the foreseen future. Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery.

The financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:

  • Drug Discovery Service(s) Offered
  • Target Identification / Validation
  • Hit Generation / Lead Identification
  • Lead Optimization
  • Therapeutic Area
  • Cardiovascular Disorders
  • CNS Disorders
  • Dermatological Disorders
  • Endocrine Disorders
  • Gastrointestinal Disorders
  • Immunological Disorders
  • Infectious Diseases
  • Musculoskeletal Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others
  • Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MENA

The “Quantum Computing in Drug Discovery Services Market 2023-2035” report features the following companies, which we identified to be key players in this domain:

  • Accenture
  • Amazon Web Services
  • Atos
  • Fujitsu
  • Huawei
  • IBM
  • Microsoft
  • Xanadu
  • XtalPi

Table of Contents

1.               Preface

2.               Executive Summary

3.               Introduction

4.               Market Landscape: Quantum Computing Software Providers

5.               Company Competitiveness Analysis

6.               Company Profiles: Software Providers

7.               Market Landscape: Hardware Providers

8.               Company Profiles: Hardware Providers

9.               Academic Grants Analysis

10.             Partnerships and Collaborations

11.             Use Case Study

12.             Porter’s Five Forces Analysis

13.             Blue Ocean Strategy

14.             Market Sizing and Opportunity Analysis

15.             Executive Insights

16.             Appendix I- Tabulated Data

17              Appendix II- List of Companies

To view more details on this report, click on the link


News article

Global Cell Free Expression Market

  Learn from experts:  do you know about these emerging industry trends? Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities

 mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Learn from our recently published whitepaper: –

Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting – the preferred research partner for global firms


Ben Johnson

+1 (415) 800 3415

[email protected]


Leave a Reply

Your email address will not be published. Required fields are marked *